Navigation Links
FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
Date:10/28/2010

already submitted REMS plan be continued after the written response from VIVUS has been submitted. The agency also requested a safety update of any new adverse events be submitted to the NDA. Finally, the FDA stated that if approved, phentermine/topiramate would be a Schedule IV drug due to the phentermine component.

As part of the written response, VIVUS plans to compile analyses integrating existing nonclinical and clinical data to provide a comprehensive assessment of the teratogenic potential of topiramate. In addition, VIVUS plans to provide several new analyses to demonstrate QNEXA does not increase the risk for major cardiovascular events, which would include data from our OB-305 and OB-204 studies. In the CRL, no new clinical studies were requested; however, in the event that any of the FDA concerns are not alleviated, additional clinical studies may be required.

"We remain confident in the efficacy and safety profile of QNEXA demonstrated in the clinical development program and look forward to continue working with the FDA towards the approval for the treatment of obesity," said Leland Wilson, chief executive officer of VIVUS. "We are preparing a comprehensive response to the CRL for submission to the FDA in approximately six weeks."

Note to InvestorsVIVUS will hold a conference call to discuss this update on Friday, October 29, 2010, beginning at 8:30 a.m. Eastern Time. Investors can listen to this call by dialing toll-free 877-359-2916 or 224-357-2386. A 30-day archive of the call can be accessed at http://ir.vivus.com/.

To access the webcast of this event, please visit VIVUS' Investors site at http://ir.vivus.com/events.cfm. A replay will also be available on demand from the website at the conclusion of the program.

About ObesityApproximately one-third of American adults (more than 72 million people) are obese, and many more
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Cardiologists at Henry Ford ... stroke in patients with an irregular heartbeat. With ... Henry Ford is able to add another option ... fibrillation, which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical trial ...
(Date:4/21/2015)... -- According to a new market ... Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), ... Contamination, Adventitious Agents) - Global Forecast to 2019", ... Market was valued at $1,758.69 Million in 2014. ... CAGR of 12.23% to reach $3,130.85 Million in ...
(Date:4/21/2015)... -- Seattle Children,s announced today that 20 of 22 ... genetically reprogrammed T cells to treat relapsed acute lymphoblastic ... sensitive tests designed to detect minute amounts of cancer ... included children with very high tumor burdens as well ... "These results are extremely encouraging," said ...
Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 2Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 3
(Date:4/21/2015)... 2015 Dr. Aaron Choroomi, dentist in ... are now offering a valuable discount on restorative dental implants. ... promotional price of only $1695 for a limited time. This ... for a limited time. , "There are times that ... the price," dental implants dentist , Dr. Choroomi, stated. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... businesses, announced today the publication of a new guide ... reform brought changes to the health insurance industry, including ... business owners to question what is permitted when implementing ... small business owners determine which HRAs are compliant this ...
(Date:4/21/2015)... 2015 Le Petit Retreat Day Spa in ... today in the leafy, historic Larchmont neighborhood, newly renamed as ... new theme of “Disconnect to Reconnect.” Tina Figueroa, a ... award-winning day spa, announces the new name and new vision ... offerings that help celebrate connections with Moms and their adult ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... announced today its CEO Rick Lindquist has been selected ... 2015. , According to Rick Lindquist, “There is a ... and Zane Benefits’ small business solutions are at its ... provided by Employee Benefit Adviser’s Rising Stars.” , According ...
(Date:4/21/2015)... April 21, 2015 Carinsurancesavings.biz has released a ... under proper surveillance and explaining the impact on a ... vehicles safe and supervised may be eligible for advantageous auto ... in a simple and efficient way. This will also help ... convenient and simple way. , Finding low cost coverage is ...
Breaking Medicine News(10 mins):Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2
... in Reducing Infections for Patients in Intensive Care , ... in southeast Pennsylvania have successfully reduced or eliminated healthcare-associated ... and are featured in the Pennsylvania Patient Safety Authority,s ... Patients in intensive care are at high risk for ...
... to Vaccinate 1.2 Million Americans - , , ... Caremark,s retail clinic division, have received the National Influenza ... Campaign. The award, co-sponsored by the American Medical ... was presented yesterday evening in Dallas as health care ...
... Physicians Association (RPA) supports Kidney Care Partners (KCP) recently ... initiative. RPA is a member of KCP, a coalition ... and nurses who work together to improve quality care ... PEAK campaign is to reduce first-year dialysis patient mortality ...
... ... estimated 15-20 million American women, sex hurts. Most suffer in silence because they ... stinging, or stabbing pain in the genital area, urinary urgency, irritable bowel, low ... or enjoying, sex. For the first time, a new book brings this taboo ...
... Amsterdam, The Netherlands: Women with cystic fibrosis can have ... long-term adverse effects on either themselves or their children, ... meeting of the European Society of Human Reproduction and ... cystic fibrosis (CF) was a death sentence and most ...
... have a diminished number of eggs in their ovaries, either ... as ovarian surgery, may be more at risk of a ... normal, fertile range. Trisomic pregnancies occur when the embryo ... two. The most common trisomy is Down,s syndrome or trisomy ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Releases June Advisory 2Health News:Pennsylvania Patient Safety Authority Releases June Advisory 3Health News:Pennsylvania Patient Safety Authority Releases June Advisory 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 5Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 2Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 2Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 4Health News:Women with cystic fibrosis can have safe and successful fertility treatment 2Health News:Women with cystic fibrosis can have safe and successful fertility treatment 3Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3
... Nidek GYC-1000 delivers a solid-state ... of energy and plugs into ... compact design and extreme portability, ... with the Nidek Phaco Emulsification ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: